
Perforation of the Nasal Septum Associated with Bevacizumab Therapy
Specialty: | Otolaryngology |
Objective: | |
ICD-10: | |
Description: | A patient receiving bevacizumab chemotherapy may develop a perforation of the nasal septum. The nasal septum is vulnerable to perforation because the cartilage is avascular and the septum is relatively thin. |
To read more or access our algorithms and calculators, please log in or register.